knowledge -WSS

knowledge

author：focus 2025-09-28 23:48:52 - browse：38235

A photograph of someone preparing small petri dishes, each holding several 1-7 day old embryos, for cells to be extracted from each embryo to test for viability at an in vitro fertilization lab — In vitro fertilization lab staff prepare small petri dishes, each holding embryos. (This sample image doesn't necessarily show embryos grown in media from CooperSurgical, a supply giant now facing lawsuits.) Michael Wyke/AP

Patients from all over the country are filing lawsuits against medical supply giant CooperSurgical, alleging that fluid the company sent to in vitro fertilization clinics destroyed their embryos.

The fluid, called culture media, is filled with nutrients that allow embryos to develop enough to ultimately be implanted into a uterus. CooperSurgical acknowledged that the batch of fluid may have stunted embryo growth in a product recall notice, but it hasn’t disclosed exactly what went wrong. Lawsuits claim the media lacked magnesium, a key nutrient, while a Cooper representative told STAT the cause is still under investigation.

The recall could be a one-off manufacturing fluke. But the debacle, and the uncertainty around the problems with the fluid, sheds light on a larger problem: IVF doctors rarely know the exact composition of culture media in the first place. The Food and Drug Administration asks manufacturers for a list of materials before the media goes on the market, an FDA spokesperson told STAT. Companies will sometimes give clinics this information voluntarily, along with required labeling information like mouse embryo data, instructions for use, and warnings. But the FDA doesn’t require companies to list the ingredients or their proportions publicly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Diversifying clinical trials isn't enough to close racial gaps: study

leisure time

WSS

Meta's Zuckerberg and Chan on track to put $50 billion into science

Humana CEO Bruce Broussard to step down in 2024

What the Wegovy shortage looks like for doctors — and for patients

Chimpanzees, like humans and whales, get menopause: Study

Akero's treatment for NASH falls short in cirrhosis study

Takeaways from AdvaMed, the largest medical devices conference

focus

knowledge

hotspot

In age of alternative facts, a scholarly course on calling out crap

Akero's treatment for NASH falls short in cirrhosis study

Medical leaders decry Supreme Court decision on affirmative action

Maker of FluMist seeks to allow at

ChatGPT in medicine: STAT answers readers' burning questions

Senate panel to vote on hospitals, PBMs, prisoner care

United colonoscopy coverage change 'may cost lives,' doctors say

Testing for cancer recurrence creates a new limbo for patients

Supreme Court strikes down use of affirmative action

What the Wegovy shortage looks like for doctors — and for patients

Wikipedia

Eight reasons why you should get an updated Covid vaccine

Massive project maps cells in human brain in unprecedented detail

STAT Readout: Today's biotech news includes Sana and Amylyx

Readout Newsletter: What happened with Sarepta's Duchenne data

Readout Newsletter: XBI biotech index, Akero Therapeutics

Humana CEO Bruce Broussard to step down in 2024

knowledge

focus

leisure time

focus